|
?xml version="1.0" encoding="utf-8"?> <!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <pre> 1. Error occurred: cannot get document summary PMID: 30151818
AÑO: 2017; IF: 4.952
|
30151818
|
de la Morena-Barrio ME, López-Gálvez R, Martínez-Martínez I, Asenjo S, Sevivas TS, López MF, Wypasek E, Entrena L, Vicente V, Corral J. Defects of splicing in antithrombin deficiency. Res Pract Thromb Haemost. 2017 Jul 14;1(2):216-222. doi: 10.1002/rth2.12025. eCollection 2017 Oct. PubMed PMID: 30046692; PubMed Central PMCID: PMC6058262.
AÑO: 2017
|
|
Corral J, de la Morena-Barrio ME, Vicente V. The genetics of antithrombin. Thromb Res. 2018 Sep;169:23-29. doi: 10.1016/j.thromres.2018.07.008. Epub 2018 Jul 5. Review. PubMed PMID: 30005274.
AÑO: 2018; IF: 3.266
|
|
Rivera-Caravaca JM, Esteve-Pastor MA, Marín F, Valdés M, Vicente V, Roldán V, Lip GYH. A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the "Real-World" vs Clinical Trials. Mayo Clin Proc. 2018 Aug;93(8):1065-1073. doi: 10.1016/j.mayocp.2018.01.028. Epub 2018 May 2. PubMed PMID: 29730090.
AÑO: 2018; IF: 11.104
|
|
Serna MJ, Rivera-Caravaca JM, Gonzalez-Conejero R, Esteve-Pastor MA, Valdés M, Vicente V, Lip GYH, Roldán V, Marín F. Pharmacogenetics of vitamin K antagonists and bleeding risk prediction in atrial fibrillation. Eur J Clin Invest. 2018 Jun;48(6):e12929. doi: 10.1111/eci.12929. Epub 2018 Apr 17. PubMed PMID: 29577257.
AÑO: 2018; IF: 5.722
|